Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.nhs.uk › vaccinations › shingles-vaccineShingles vaccine - NHS

   www.nhs.uk › vaccinations › shingles-vaccine

   • Zapisane w pamięci cache

   Everyone aged 70 to 79 is eligible for the shingles vaccine. Contact your GP surgery if you missed your vaccine. You're eligible up until your 80th birthday (but you can have your 2nd dose up until your 81st birthday). People aged 50 and over with a severely weakened immune system.

2. www.gov.uk › government › publicationsShingles immunisation programme: information for healthcare ...

   www.gov.uk › government › publications

   • Zapisane w pamięci cache

   23 sie 2024 · Based on the findings of the cost-effectiveness analysis, JCVI recommended a universal routine herpes zoster (shingles) vaccination programme using a single dose of the live Zostavax shingles...

3. www.gov.uk › government › publicationsShingles vaccine coverage (England): annual report of the...

   www.gov.uk › government › publications

   • Zapisane w pamięci cache

   14 maj 2024 · The aim of the routine shingles (herpes zoster) vaccination programme is to prevent severe morbidity from shingles in groups at the highest risk. The shingles vaccination programme began on 1...

4. www.gov.uk › government › publicationsShingles vaccine coverage (England): report for quarter 3 of the...

   www.gov.uk › government › publications

   • Zapisane w pamięci cache

   14 maj 2024 · As a live viral vaccine, the Zostavax shingles vaccine is contra-indicated for immunosuppressed individuals. From 1 September 2021, these individuals have been offered the recombinant Shingrix...

5. www.ema.europa.eu › en › medicinesShingrix | European Medicines Agency (EMA)

   www.ema.europa.eu › en › medicines

   • Zapisane w pamięci cache

   Shingrix is a vaccine used in adults aged 50 years and over to protect against shingles (herpes zoster) and post-herpetic neuralgia (long-lasting nerve pain following shingles). It can also be used from the age of 18 years and over in adults who are at increased risk of herpes zoster.

6. www.england.nhs.uk › wp-content › uploadsShingrix® Herpes Zoster Vaccine Patient Group Direction (PGD)

   www.england.nhs.uk › wp-content › uploads

   This PGD is for the administration of Shingrix® Herpes Zoster Vaccine (recombinant, adjuvanted), for the prevention of herpes zoster (‘zoster’ or shingles) and herpes zoster-related post-herpetic neuralgia (PHN), to individuals who are eligible for the national shingles immunisation programme.

7. assets.publishing.service.gov.uk › government › uploadsShingles vaccine coverage report (adults eligible from April to...

   assets.publishing.service.gov.uk › government › uploads

   The aim of the routine shingles (herpes zoster) vaccination programme is to prevent severe morbidity from shingles in groups at the highest risk. The shingles vaccination programme began on 1...